The observations in this case diverge from the prevailing pattern, as most side effects involving ICIs predominantly affect the thyroid or an isolated ACTH deficiency, with hypophysitis being the least common side effect, even more so in the case of anti-PD1 agents [4]. This evidence concerns the gene PDCD1 and hypophysitis.